Donate to Cure It On The Court

Help Cure Childhood Cancer
Donation Goal For This Project is $10,000
58% Donated/$4,116 To Go
Donate Now

In 2015, Comer Children’s Hospital marked its first decade of outstanding contributions in the care of children. Since opening in 2005, Comer Children’s has cared for hundreds of thousands of young patients— from Chicago, the United States, and around the world—including 51,000 inpatients, 369,000 outpatients, and 8,000 newborns and infants in its Margaret M. and George A. Stephen Neonatal Intensive Care Unit. Comer Children’s provides the optimal setting for cutting-edge diagnostic, therapeutic, and surgical technologies to flourish in a family-focused environment.

Our multidisciplinary approach to pediatric cancer care leads to collaborative treatment plans best suited for each patient, with more than 80 clinical trials underway at any one time. Yet pediatric cancer remains a major cause of non-traumatic childhood mortality. Improving patient outcomes requires an enhanced understanding of the molecular basis of these diseases. To that end, our faculty members are conducting research to:

  • Link genomic and clinical data to improve outcomes for neuroblastoma, the most common cancer in infants and toddlers;
  • Use advanced DNA sequencing strategies to guide treatment decisions for currently incurable pediatric tumors;
  • Decrease the risk of relapse after bone marrow transplant in patients with leukemia, lymphomas, or solid tumors through the development of novel drugs;
  • Develop a new class of molecularly-engineered drugs that encourage anti-tumor immune responses and trigger cancer cell death.

Comer Children’s is committed to providing quality, holistic care to our patients. We are one of the largest providers of uncompensated medical care in Illinois and leaders in offering supportive oncology. In 2012, Wendy Stock, MD, and the late James Nachman, MD, established the first Adolescent and Young Adult (AYA) Oncology Clinic in the city of Chicago to identify high-risk AYA patients with blood cancers. This collaborative group offers coordinated care and focuses on the personal, psychosocial, and medical challenges associated with treatment to improve patient outcomes.

Click here for our 501(C)(3) Letter